Jalks Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 112.25%
(FY 2020)
- Profit 26.62%
(FY 2020)
- Ebitda 164.64%
(FY 2020)
- Net Worth 28.11%
(FY 2020)
- Total Assets 8.90%
(FY 2020)
About Jalks Pharmaceuticals
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Tarakaramarao Bodepudi, Nallabotu Kumar, Harish Nara, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TN2018PTC121411
- Company No.
121411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jalks Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarakaramarao Bodepudi  | Director | 14-Mar-2018 | Current |
| Nallabotu Kumar | Director | 14-Mar-2018 | Current |
| Harish Nara | Director | 22-May-2018 | Current |
| Keerthi Nagalla | Director | 14-Mar-2018 | Current |
Financial Performance of Jalks Pharmaceuticals.
Jalks Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 112.25% increase. The company also saw a substantial improvement in profitability, with a 26.62% increase in profit. The company's net worth Soared by an impressive increase of 28.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jalks Pharmaceuticals?
Unlock access to Jalks Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jalks Pharmaceuticals?
Unlock and access historical data on people associated with Jalks Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jalks Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jalks Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
